期刊文献+

转录因子Twist及其相关因子N-cadherin在胰腺癌中的表达及意义 被引量:2

Expression and role of Twist and N-cadherin in pancreatic cancer
原文传递
导出
摘要 目的探讨转录因子Twist及其下游相关因子N—cadherin在人胰腺癌组织中的表达及与肿瘤临床病理特征、患者预后的关系。方法采用免疫组化MaxVision两步法分别检测62例胰腺癌组织和10例正常胰腺组织中Twist及N-cadherin的表达,分析二者表达与临床病理特征及患者预后的相关性。结果Twist在胰腺癌组织的阳性表达率明显高于正常胰腺组织(96.8%比30.0%,P〈0.01),N-cadherin在胰腺癌组织的阳性表达率也明显高于正常胰腺组织(75.8%比0,P〈0.01),但两者的表达无明显相关性(r=0.100,P=0.441)。Twist及N-cadherin表达与胰腺癌TNM分期、淋巴结转移、门静脉或神经浸润、肿瘤部位均密切相关(P值均〈0.05),与患者年龄、性别及肿瘤分化程度均无明显相关性(P值均〉0.05)。胰腺癌患者术后生存期随Twist表达的增强而缩短,但与N.cadherin表达强度无明显相关性。TNM分期、Twist表达强度是影响胰腺癌患者预后的独立因素。结论胰腺癌组织Twist及N-cadherin均高表达,其表达与胰腺癌的恶性生物学行为相关,Twist的异常表达可能是评估胰腺癌患者预后的潜在指标。 Objective To investigate the expression of Twist and N-cadherin in pancreatic cancer, and to study its relationship with clinicopathological parameters and patients' prognosis. Methods The expression of the Twist and N-cadherin in 62 tissue samples from patients with pancreatic ductal adencocarcinoma and 10 normal pancreatic tissue samples was determined by using immunohistochemistry MaxVision two step method ,and the relationship with clinicopathological parameters and patients' prognosis was analyzed. Results The positive expression rate of Twist in pancreatic cancer was higher than that of normal pancreatic tissues (96.8% vs. 30%, P 〈0.01 ), and the positive expression rate of N-cadherin was higher than that of normal pancreatic tissues (75.8% vs. O, P 〈0.01 ), but there was no correlation between them (r =0. 100, P =0.441 ). The expressions of Twist and N-cadherin was significantly correlated with TNM stage, lymph node metastasis, infiltration of portal vein or nerves and tumor location ( P 〈 0.05 ), but not with age, gender and degree of differentiation ( P 〉 0.05 ). The post-operative survival of patients decreased with the increasing Twist expression, but the survival was not associated with the expression of N-cadherin. TNM stage, the expression of Twist was independent predictive factors of prognosis for pancreatic cancer patients. Conclusions Twist and N-cadherin are highly expressed in pancreatic cancer, and the expression was associated malignant behavior of pancreatic cancer. The abnormal expression of Twist may be a potential marker for prognosis evaluation of pancreatic cancer patients.
作者 张喆 陈少夫
出处 《中华胰腺病杂志》 CAS 2012年第4期238-241,共4页 Chinese Journal of Pancreatology
关键词 胰腺肿瘤 TWIST转录因子 N-CADHERIN Pancertic neoplasms Twist transcription factor N-cadherin
  • 相关文献

参考文献12

  • 1Gotzmann J, Mikula M, Eger A, et al. Molecular aspects of epithelial cell plasticity: implications for local for local tumor invasion and metastasis. Murat Res ,2004,566:9-20.
  • 2Thiery JP. Epithelial-mesenchymal transitions in tumor progression. Nat Rev Cancer, 2002,2:442-454.
  • 3Martin TA, Goyal A, Watkins G, et al. Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast. Cancer, 2005,12:488-496.
  • 4Tran NL, Adams DG, Vaillancourt RR, et al. Signal transduction from N-cadherin increases Bcl-2. Regulation of the phosphatidylinositol 3-kinase/Akt pathway by homophilic adhesion and actin cytoskeletal organization. J Biol Chem,2002,277:32905- 32914.
  • 5Kang Y, Massagu6 J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell, 2004,118:277-279.
  • 6Zhou WL, Wang Y,Zhou XL, et al. Short interfering RNA directed against TWIST, a novel zinc finger transcription factor, increases A549 cell sensitivity to via MAPK/mitoehondrial pathway. Biochem Biophys Res Commum,2008,369 : 1098-1102.
  • 7Kasimir-Bauer S, Hoffmann O, Wallwiener D, et al. Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancerpatients with circulating tumor ceils. Breast Cancer Res, 2012,14:R15.
  • 8Rosivatz E, Becker I, Specht K, et al. Differential expression of the eithelial-mesenchymal transitions regulators snail, SIP1, and twist in gastric cancer. Am J Pathol, 2002,161:1881-1891.
  • 9Loboda A, Nebozhyn MV,Watters JW,et al. EMT is the dominant program in human colon cancer. BMC Med Genomics ,2011,4:9.
  • 10De Wever O, Pauwels P, De Craene B, et al. Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front. I-Iistochem Cell Bio1,2008 ,130 :481-494.

同被引文献22

  • 1Saji S.Evolving approaches to metastatic breast cancer patientspre-treated with anthracycline and taxane[J].Bio Drugs,2013,27(5):469-478.
  • 2Donovan D.Metastatic breast cancer epidemiology and manage-ment with a focus on taxanes[J].Clin J Oncol Nurs,2013,17 Suppl:5-8.
  • 3Gao JP,Chen CX,Gu WL,et al.Effects of polydatin on attenuatingventricular remodeling in isoproterenol-induced mouse and pressure-overload rat models[J].Fitoterapia,2010,81(7):953-960.
  • 4Wang X,Song R,Chen Y,et al.Polydatin-a new mitochondriaprotector for acute severe hemorrhagic shock treatment[J].Ex-pert Opin Investig Drugs,2013,22(2):169-179.
  • 5Wang X,Song R,Bian HN,et al.Polydatin,a natural polyphe-nol,protects arterial smooth muscle cells against mitochondrialdysfunction and lysosomal destabilization following hemorrhagicshock[J].Am J Physiol Regul Integr Comp Physiol,2012,302(7):R805-814.
  • 6Miao Q,Wang S,Miao S,et al.Cardioprotective effect of poly-datin against ischemia/reperfusion injury;roles of protein kinaseC and mito K(ATP)activation[J].Phytomedicine,2011,19(1):8-12.
  • 7Indraccolo U,Barbieri F.Effect of palmitoylethanolamide-poly-datin combination on chronic pelvic pain associated with endome-triosis:preliminary observations[J].Eur J Obstet Gynecol Re-prod Biol,2010,150(1):76-79.
  • 8Yao J,Wang JY,Liu L,et al.Polydatin ameliorates DSS-in-duced colitis in mice through inhibition of nuclear factor-kappaBactivation[J].Planta Med,2011,77(5):421-427.
  • 9Liu H,Zhao S,Zhang Y,et al.Reactive oxygen species-mediated en-doplasmic reticulum stress and mitochondrial dysfunction contribute topolydatin-induced apoptosis in human nasopharyngeal carcinoma CNEcells[J].J Cell Biochem,2011,112(12):3695-3703.
  • 10Zhang Y,Zhuang Z,Meng Q,et al.Polydatin inhibits growth oflung cancer cells by inducing apoptosis and causing ceil cycle ar-rest[J].Oncol Lett,2014,7(1):295-301.

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部